The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.10625
Bid: 0.104
Ask: 0.1095
Change: 0.00 (0.00%)
Spread: 0.0055 (5.288%)
Open: 0.10625
High: 0.00
Low: 0.00
Prev. Close: 0.10625
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Collaboration with Team Sky

14 Mar 2018 07:00

RNS Number : 6148H
Versarien PLC
14 March 2018
 

14 March 2018

Versarien plc

("Versarien" or the "Company")

Collaboration with Team Sky

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce that it has entered into a collaboration agreement with professional cycling team, "Team Sky".

Versarien and Team Sky have agreed to collaborate to explore the benefits of adding graphene to high performance cycling equipment used by Team Sky. These products may include cycle frames, wheels and tyres, together with rider helmets and further rider apparel.

It is intended that Versarien's proprietary Nanene few layer graphene nano-platelets and graphene inks will be evaluated in the design and development of new and future products to ascertain any performance benefits that can be gained from improvements in material strength and impact absoprtion, material weight, and thermal radiation properties through the addition of graphene.

Carsten Jeppesen, Head of Technical Operations, Team Sky, commented: "This collaboration with Versarien provides us with a unique opportunity to explore the application of new and emerging materials in high performance cycling. Alongside our current performance partners we are developing a diverse network of innovation expertise in Britain and across Europe to support our riders' ambitions."

Neill Ricketts, CEO of Versarien, commented: "We are delighted to be working with Team Sky, the most successful Tour de France team in recent times, to bring the benefits of graphene enhanced materials to professional cycling.

"Professional cycling has always been at the forefront of technical innovation and the rapid adoption of new materials when they can provide a performance advantage. The success of Team Sky has been developed on the 'marginal gain' philosophy of seeking performance advantage in all elements that contribute to winning races. Team Sky recognise the potential for graphene enhanced materials to aid performance and this wide ranging collaboration will therefore look across both the cycle components and rider apparel to identify areas where additional performance can be gained through the use of graphene.

"Elite sport is the ideal showcase for our graphene technology as we continue to develop relationships with global organisations to bring graphene enhanced products to market."

 

Enquiries:

Versarien

Neill Ricketts, CEO

Chris Leigh, CFO

01242 269 122

WH Ireland (Nominated Advisor)

Mike Coe

Ed Allsopp

0117 945 3470

IFC Advisory (Financial PR and IR)

Tim Metcalfe

Graham Herring

Heather Armstrong

0203 934 6630

 

About Team Sky

Team Sky is a British professional cycling team that competes in the UCI World Tour. The team is based at the National Cycling Centre in Manchester, England, with a logistics base in Deinze, Belgium. The team is managed by Sir Dave Brailsford.

Team Sky launched in 2010 with the ambition of winning the Tour de France with a British rider within five years, a goal achieved within just three years when Bradley Wiggins won the 2012 Tour de France, becoming the first British winner in its history, while teammate and fellow Briton Chris Froome finished as the runner up and then went on to win the 2013, 2015, 2016 and 2017 Tours, as well as the Vuelta a España in 2017.

About Versarien

Versarien plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has five subsidiaries operating under two divisions:

Graphene and Plastics

2-DTech Ltd, which specialises in the supply, characterisation and early stage development of graphene products. www.2-dtech.com

AAC Cyroma Ltd, which specialises in the supply of vacuum-formed and injection-moulded products to the automotive, construction, utilities and retail industry sectors. Using Versarien's existing graphene manufacturing capabilities, AAC will have the ability to produce graphene-enhanced plastic products. www.aaccyroma.co.uk  

Cambridge Graphene Ltd, which supplies novel inks based on graphene and related materials, using patented processes and develops graphene materials technology for licensing to manufacturers. www.cambridgegraphene.com

Thermal and Hard Wear Products

Versarien Technologies Ltd. which has developed an additive process for creating advanced micro-porous metals targeting the thermal management industry and supplies extruded aluminium. www.versarien-technologies.co.uk 

Total Carbide Ltd, a leading manufacturer in sintered tungsten carbide for applications in arduous environments such as the oil and gas industry. www.totalcarbide.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTJJMFTMBIBBLP
Date   Source Headline
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation
2nd Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.